Belite Bio Announces Uplisting to the Nasdaq Global Select Market
Belite Bio received Nasdaq approval to transfer its listing from the Nasdaq Capital Market to the Nasdaq Global Select Market, effective at the open on October 19, 2026, under the existing ticker BLTE. The Global Select Market is Nasdaq's highest tier with more stringent financial and liquidity standards, and the company expects the move to enhance institutional visibility, improve liquidity, and broaden market recognition.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.